Biden-Sanders Unity Task Force Releases Recommendations on Cannabis

Foley Hoag LLP - Cannabis and the Law

Foley Hoag LLP - Cannabis and the Law

As part of sweeping recommendations touching upon subjects ranging from climate change to criminal justice reform to healthcare, the Biden-Sanders Unity Task Force Recommendations recently previewed a framework for federal cannabis regulation under a Biden administration.  Although the framework is thin on details, it reaffirms the widely-held belief among Democrats that the federal government should decriminalize cannabis and take affirmative steps to erase the scars of past criminal convictions arising from cannabis use.

Most importantly, the recommendations confirm that the Biden administration would decriminalize cannabis use and reschedule it through executive action on the federal level.  In turn, they also confirm that the Biden administration would not shoehorn the Justice Department into launching federal prosecutions of conduct that is legal at the state level.  Rather, the Biden administration would support legalization of medicinal cannabis at the state level and leave it to the states to make their own decisions about recreational use.  This more welcoming federal policy may accelerate the proliferation of adult-use cannabis laws and regulations across the nation.

Finally, the recommendations also address the continuing fallout from decades of enforcement of criminal laws related to cannabis.   They boldly declare that “[a]ll past criminal convictions for cannabis use should be automatically expunged” and forecast the removal of cannabis use from the list of deportable offenses.  In addition, the recommendations call on states to re-invest tax revenue from the cannabis industry to repair damage to Black and brown communities that have been disproportionately disadvantaged by the criminalization of cannabis.

Despite these lofty reparative goals, the recommendations provide scant details on implementation.  Likewise, the recommendations do not feature any FDA or CMS policies on medicinal cannabis, nor do they address how this more permissive federal posture might (or should) lead to greater banking access for the cannabis industry.  As the Biden campaign continues to fill out this initial Task Force framework, more details are sure to follow.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Foley Hoag LLP - Cannabis and the Law | Attorney Advertising

Written by:

Foley Hoag LLP - Cannabis and the Law

Foley Hoag LLP - Cannabis and the Law on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.